Crizotinib plus erlotinib overcomes osimertinib resistance in a seriously-ill non-small cell lung cancer patient with acquired MET amplification-中国期刊网

首页 > 《中华医学杂志（英文版）》 > 2021年03期 > Crizotinib plus erlotinib overcomes osimertinib resistance in a seriously-ill non-small cell lung cancer patient with acquired MET amplification

（整期优先）网络出版时间：2021-03-07

作者: Zhao Zhi-Mei Wang Song-Ping Sun Lei Ji You-Xin

医药卫生 >

同系列资源

/ 1

无

同系列内容

《中华医学杂志（英文版）》2021年03期 - Corrigendum: Clinical characteristics and outcomes of hypersensitivity pneumonitis: a population-based study in China 2021-03-07 8
《中华医学杂志（英文版）》2021年03期 - Successful laparoscopic management of ovarian cyst torsion in the third trimester 2021-03-07 9
《中华医学杂志（英文版）》2021年03期 - Crizotinib plus erlotinib overcomes osimertinib resistance in a seriously-ill non-small cell lung cancer patient with acquired MET amplification 2021-03-07 6
《中华医学杂志（英文版）》2021年03期 - Perfect prognosis of a boy with alveolar rhabdomyosarcoma of the nasal wing treated with brachytherapy and chemotherapy 2021-03-07 1
《中华医学杂志（英文版）》2021年03期 - Hemorrhagic stroke caused by moyamoya disease in a patient with obstructive hypertrophic cardiomyopathy 2021-03-07 13

查看全部

来源期刊

中华医学杂志（英文版）

中华医学杂志（英文版）

相关推荐

同分类资源更多

相关关键词

返回顶部